Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Total Debt (2017 - 2025)

Vycor Medical has reported Total Debt over the past 12 years, most recently at $135831.0 for Q4 2025.

  • Quarterly Total Debt fell 2.59% to $135831.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $135831.0 through Dec 2025, down 2.59% year-over-year, with the annual reading at $135831.0 for FY2025, 2.59% down from the prior year.
  • Total Debt was $135831.0 for Q4 2025 at Vycor Medical, down from $136745.0 in the prior quarter.
  • Over five years, Total Debt peaked at $150000.0 in Q1 2021 and troughed at $135831.0 in Q4 2025.
  • The 5-year median for Total Debt is $144176.0 (2023), against an average of $143917.0.
  • The largest YoY upside for Total Debt was 0.0% in 2021 against a maximum downside of 94.32% in 2021.
  • A 5-year view of Total Debt shows it stood at $150000.0 in 2021, then fell by 2.5% to $146253.0 in 2022, then dropped by 2.29% to $142908.0 in 2023, then dropped by 2.43% to $139436.0 in 2024, then dropped by 2.59% to $135831.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Total Debt are $135831.0 (Q4 2025), $136745.0 (Q3 2025), and $137651.0 (Q2 2025).